Abstract
Local progression, in patients with hormone-refractory prostate cancer, often causes significant morbidity. Pelvic radiotherapy (RT) provides effective palliation in this setting, with most published studies supporting the use of high-dose regimens. The aim of the present study was to examine the role of split-course hypofractionated RT used at our institution in treating this group of patients. A total of 34 men with locoregionally progressive hormone-refractory prostate cancer, treated with a split course of pelvic RT (45-60 Gy in 18-24 fractions) between 2000 and 2008 were analyzed. The primary endpoints were the response rate and actuarial locoregional progression-free survival. Secondary endpoints included overall survival, compliance, and acute and late toxicity. The median age was 71 years (range, 53-88). Treatment resulted in an overall initial response rate of 91%, a median locoregional progression-free survival of 43 months, and median overall survival of 28 months. Compliance was excellent and no significant late toxicity was reported. The split course pelvic RT described has an acceptable toxicity profile, is effective, and compares well with other high-dose palliative regimens that have been previously reported.
References
Nov 1, 1990·British Journal of Urology·H G KynastonP N Matthews
Sep 1, 1991·International Journal of Radiation Oncology, Biology, Physics·P P LaiJ D Cox
Oct 1, 1987·International Journal of Radiation Oncology, Biology, Physics·W J SpanosJ Stetz
Nov 1, 1995·International Journal of Radiation Oncology, Biology, Physics·S P LankfordG K Zagars
Nov 1, 1995·British Journal of Urology·B OtnesS D Fosså
May 5, 1999·International Journal of Urology : Official Journal of the Japanese Urological Association·Y FuruyaH Ito
Aug 10, 2000·BJU International·E H HernesP A Koivisto
May 19, 2001·Best Practice & Research. Clinical Obstetrics & Gynaecology·S C Smith, W J Koh
Oct 9, 2003·The Journal of Urology·Ashish M KamatLouis L Pisters
Jan 10, 2004·The Journal of Urology·Donald S CrainChristopher J Kane
Oct 26, 2007·Australasian Radiology·B HindsonV Do
Dec 18, 2007·Seminars in Radiation Oncology·Edward F Miles, W Robert Lee
May 26, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Omar S DinPeter Kirkbride
Citations
Sep 24, 2013·Journal of Cancer Research and Clinical Oncology·Angela BotticellaUmberto Ricardi
Apr 30, 2013·Surgical Oncology Clinics of North America·Bridget F Koontz, W Robert Lee
Dec 3, 2014·Clinical Oncology : a Journal of the Royal College of Radiologists·R WhiteF Foroudi
Jun 30, 2016·International Journal of Surgery·Alfonso ReginelliSalvatore Cappabianca
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen T LutzEdward Chow
Jul 15, 2015·Therapeutic Advances in Urology·Jim N Rose, Juanita M Crook
Sep 12, 2014·British Journal of Cancer·M MichaelS Y Ngan
Mar 21, 2018·International Journal of Clinical Oncology·Rihito AizawaTakashi Mizowaki
Jan 12, 2019·Radiation Oncology·Jesper CarlNiels Henrik Holländer
Apr 30, 2017·Molecular and Clinical Oncology·Teele KuuskMarkku H Vaarala
May 7, 2021·Scientific Reports·Mami OgitaKeiichi Nakagawa
Nov 29, 2020·Clinical Genitourinary Cancer·Raj R BhanvadiaAditya Bagrodia
Jun 1, 2021·Surgical Oncology Clinics of North America·Graeme R WilliamsJoshua A Jones